APVO stock was acquired by a variety of institutional investors in the last quarter, including Ghost Tree Capital LLC, Alyeska Investment Group L.P., Alyeska Investment Group L.P., BlackRock Inc., Stonepine Capital Management LLC, Dynamic Technology Lab Private Ltd, Northern Trust Corp, and Pura Vida Investments LLC. Company insiders that have bought Aptevo Therapeutics stock in the last two years include Barbara Lopez Kunz, Daniel Abdun-Nabi, Fuad El-Hibri, Grady Grant III, Kevin C Tang, Marvin L White, Randy Joe Maddux, and Zsolt Harsanyi.
View insider buying and selling activity for Aptevo Therapeutics or or view top insider-buying stocks.